Literature DB >> 30717898

Neck Dissection in the Surgical Treatment of Thyroid Cancer.

Ahmad M Eltelety1, David J Terris2.   

Abstract

The incidence of thyroid cancer is increasing, largely attributable to overdetection related to prevalent diagnostic and radiologic imaging modalities. Papillary thyroid cancer remains the most common thyroid malignancy. It has a high tendency for regional metastasis to the cervical lymph nodes. The optimal management of the neck in patients with thyroid carcinoma has long been an important topic of debate. This article addresses central and lateral neck dissection, providing a simplified guide to the most up-to-date and evidence-based practices.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lymph node; Metastasis; Neck dissection; Thyroid cancer; Thyroidectomy

Mesh:

Year:  2018        PMID: 30717898     DOI: 10.1016/j.ecl.2018.11.004

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  4 in total

1.  Prophylactic central lymph node dissection performed selectively with cN0 papillary thyroid carcinoma according to a risk-scoring model.

Authors:  Xiang Zhong; Yunpeng Lu; Xu Yin; Quhui Wang; Feiran Wang; Zhixian He
Journal:  Gland Surg       Date:  2022-02

2.  Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma.

Authors:  Jing Zhou; Da-Xue Li; Han Gao; Xin-Liang Su
Journal:  World J Clin Cases       Date:  2022-04-26       Impact factor: 1.534

3.  Deltex3 inhibits Epithelial Mesenchymal Transition in Papillary Thyroid Carcinoma via promoting ubiquitination of XRCC5 to regulate the AKT signal pathway.

Authors:  Lidong Wang; Yonglian Huang; Chenxi Liu; Mingyue Guo; Zhennan Ma; Jingni He; Ailian Wang; Xiaodan Sun; Zhen Liu
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

4.  Total or Near-total Thyroidectomy in treatment of Thyroid Cancer.

Authors:  Gang Li; Lihong Wu
Journal:  Pak J Med Sci       Date:  2022 Jul-Aug       Impact factor: 2.340

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.